Neutral impactIPO

Paras Healthcare IPO Day 1: Subscription Status, Timeline & Key Issue Details

Groww 6 hrs ago·21 Oct 2026, 5:16 am

Paras Healthcare has launched its initial public offering (IPO) to raise funds for corporate purposes and to strengthen its financial base. The issue opened for subscription on a fixed price basis, allowing retail investors to apply for shares directly without the usual price band. This structure simplifies the application process for individual investors looking to participate in the company's growth story.

For investors, the IPO is significant as it offers an opportunity to invest in one of the largest private hospital chains in India. The company's strong market presence and expanding network in Tier 2 and Tier 3 cities make it an attractive proposition. However, the success of the issue will depend on the overall market sentiment and the response from different investor categories.

Investors should keep an eye on the subscription status over the next few days and the eventual allotment date. The listing plans and the post-issue market performance will also be crucial factors to watch. It is advisable to review the company's financials and risk factors carefully before making an investment decision.

Excerpt from Groww

Paras Healthcare's ₹1,450 crore initial public offering (IPO) opened for public subscription today, October 21, 2026, with a price band of ₹660 to ₹693 per share. As of 10:21 A.M. on the first day of bidding, the issue had been subscribed 0.02 times. The IPO will close on October 23, 2026. The allotment is expected on…
Read the original at Groww

Key takeaways

  • Category: IPO.
  • Assessed as a significant, market-relevant update.

Why it matters

A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Groww.

More IPO news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.